Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-03-06 @ 12:08 PM
Study NCT ID:
NCT05076851
Status:
UNKNOWN
Last Update Posted:
2021-10-13
First Post:
2021-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer
Sponsor:
Hongqian Guo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-22
First Submit QC Date:
None
Study First Post Date:
2021-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-12
Last Update Post Date:
2021-10-13
Last Update Post Date Type:
ACTUAL